Literature DB >> 20706754

Sialidosis type I with neoplasms in siblings: the first clinical cases.

Yohsuke Yagi, Akira Machida, Shuta Toru, Takayoshi Kobayashi, Toshiki Uchihara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20706754     DOI： 10.1007/s10072-010-0392-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  9 in total

1.  Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression.

Authors:  Masashi Sawada; Setsuko Moriya; Seiichi Saito; Ryuzaburo Shineha; Susumu Satomi; Takao Yamori; Takashi Tsuruo; Reiji Kannagi; Taeko Miyagi
Journal:  Int J Cancer       Date:  2002-01-10       Impact factor: 7.396

2.  Down-regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers.

Authors:  Hideaki Yamanami; Kazuhiro Shiozaki; Tadashi Wada; Kazunori Yamaguchi; Takuji Uemura; Yoichiro Kakugawa; Tsuneaki Hujiya; Taeko Miyagi
Journal:  Cancer Sci       Date:  2007-03       Impact factor: 6.716

3.  Genetic variants in epigenetic genes and breast cancer risk.

Authors:  Arancha Cebrian; Paul D Pharoah; Shahana Ahmed; Santiago Ropero; Mario F Fraga; Paula L Smith; Don Conroy; Robert Luben; Barbara Perkins; Douglas F Easton; Alison M Dunning; Manel Esteller; Bruce A J Ponder
Journal:  Carcinogenesis       Date:  2006-02-25       Impact factor: 4.944

4.  Activated sialidase activity in transformed lymphocytes by Epstein-Barr (EB) virus of sialidosis type I (cherry-red spot-myoclonus syndrome).

Authors:  M Yamamoto; T Yamauchi; K Yamamoto; T Kobayashi
Journal:  J Neurol Sci       Date:  1995-07       Impact factor: 3.181

5.  Molecular and structural studies of Japanese patients with sialidosis type 1.

Authors:  Y Naganawa; K Itoh; M Shimmoto; K Takiguchi; H Doi; Y Nishizawa; T Kobayashi; S Kamei; K E Lukong; A V Pshezhetsky; H Sakuraba
Journal:  J Hum Genet       Date:  2000       Impact factor: 3.172

Review 6.  Molecular pathology of NEU1 gene in sialidosis.

Authors:  Volkan Seyrantepe; Helena Poupetova; Roseline Froissart; Marie-Thérèse Zabot; Irène Maire; Alexey V Pshezhetsky
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

7.  Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells.

Authors:  Volkan Seyrantepe; Karine Landry; Stéphanie Trudel; Jacob A Hassan; Carlos R Morales; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2004-06-22       Impact factor: 5.157

8.  Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia.

Authors:  Toshiki Uchihara; Ken-ichi Ohashi; Masanobu Kitagawa; Morito Kurata; Ayako Nakamura; Katsuiku Hirokawa; Tsutomu Kasuga; Takayoshi Kobayashi
Journal:  Acta Neuropathol       Date:  2009-05-05       Impact factor: 17.088

Review 9.  Aberrant expression of sialidase and cancer progression.

Authors:  Taeko Miyagi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2008       Impact factor: 3.493
  9 in total
  1 in total

1.  Regulated lysosomal exocytosis mediates cancer progression.

Authors:  Eda Machado; Shai White-Gilbertson; Diantha van de Vlekkert; Laura Janke; Simon Moshiach; Yvan Campos; David Finkelstein; Elida Gomero; Rosario Mosca; Xiaohui Qiu; Christopher L Morton; Ida Annunziata; Alessandra d'Azzo
Journal:  Sci Adv       Date:  2015-12-18       Impact factor: 14.136
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.